Summit Global Investments - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2023$2,315
+1.5%
96,485
-1.8%
0.18%
-7.3%
Q4 2022$2,281
-99.9%
98,301
+0.4%
0.19%
+33.1%
Q3 2022$1,569,000
-19.9%
97,934
-11.5%
0.14%
-16.2%
Q2 2022$1,960,000
+77.2%
110,606
+103.7%
0.17%
+111.0%
Q1 2022$1,106,000
-26.1%
54,300
-32.2%
0.08%
-14.6%
Q4 2021$1,496,000
+9.8%
80,100
+16.1%
0.10%
-5.9%
Q3 2021$1,362,000
+100.9%
69,000
+140.4%
0.10%
+148.8%
Q2 2021$678,00028,7000.04%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,887,332$27,819,0005.09%
SECTORAL ASSET MANAGEMENT INC 1,989,455$29,325,0003.11%
J. Goldman & Co LP 1,581,885$23,317,0001.63%
Eventide Asset Management 2,207,610$32,540,0001.20%
Rock Springs Capital Management LP 1,650,100$24,322,0000.88%
HAMILTON LANE ADVISORS LLC 114,489$2,0000.81%
RICE HALL JAMES & ASSOCIATES, LLC 565,942$8,342,0000.30%
HIGHLAND CAPITAL MANAGEMENT LP 337,429$4,973,0000.27%
Cortina Asset Management, LLC 393,436$5,799,0000.27%
Cormorant Asset Management, LP 250,000$3,685,0000.24%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders